Medanta Stock Up by More Than 5%, After June Quarter Profit Increases by 49.6%

Mumbai, August 8, 2025 – Shares of Global Health Limited (NSE: MEDANTA, BSE: 543654) touched 52-week high in early trade today, 8th August. This, after the company achieved its best result to date during the quarter. Its net profit jumped 49.6% on a year-on-year basis. The positive outcome was because of more patients, better prices, and strong growth in newer hospitals, the company said

At 12:30 p.m. 8th August, the stock is up by 5.43%, trading at Rs 1,399.

Stock Performance Snapshot

At 11:02 AM on 08-Aug-2025, the shares of Global Health Limited were trading at ₹1,412.60, up 6.45% from the previous close. The stock hit an intraday high of ₹1,428.00, which is also a new 52-week high for the company, generating a turnover of ₹252.80 crore and a VWAP of ₹1,404.85 so far.

Factors Contributing To the Stock Rally

Investors are reacting positively to Medanta’s operational strength:

Occupancy

The healthcare major reported its occupancy to be at 63.2% which was supported by an increase in bed capacity.

Average Revenue Per Occupied Bed (ARPOB)

The company ARPOB increased by 4.0% to ₹66,584, which reflects improved revenue per occupied bed.

Developing Hospitals

Revenue from the company’s developing hospitals grew by 35.9% on a year-on-year basis, with its EBITDA rising by 59.8%.

International Patients Revenue

The hospital major’s international patient revenue increased by 33.8% on a year-on-year basis, highlighting that it has a strong overseas demand.

Profit Surge on Strong Operating Performance in Q1 FY26

The solid Q1 FY26 performance of the company was led by double-digit growth in revenue and profitability. The results highlight that the quarter saw topline strength and efficiency gains that combined to deliver robust earnings momentum.

Revenue

Revenue from operations rose nearly 20% year-on-year, supported by higher material consumption and employee-related costs in line with business expansion.

EBITDA

EBITDA increased over 22%, with margins improving by about 70 basis points despite higher expenses.

Profit After Tax

Profit after tax grew almost 50%, reflecting strong operational leverage and disciplined cost management.

Key Takeaways

The recent rally can continue if the company sustains higher occupancy and ARPOB while keeping costs in check.

Rising international patient revenue supports margins but could be vulnerable to currency or geopolitical risks.

Upcoming capacity additions in Lucknow and Indore may impact margins in the short term despite long-term growth potential.

Valuations look stretched, so any lack of earnings upgrades could lead to a short-term correction.

About Company

Global Health Limited, founded by renowned surgeon Dr. Naresh Trehan, operates as one of the largest private multi-specialty tertiary care providers in North and East India. Headquartered in Gurgaon, it is listed in the healthcare services industry and runs hospitals under the “Medanta” brand. The company offers advanced care across 30+ specialties, supported by over 2,000 doctors and a growing hospital network.

REF:https://nsearchives.nseindia.com/corporate/MEDANTA21_07082025185817_GHLPRESSRELEASE07AUG2025FINALSIGNED.pdf

https://www.nseindia.com/get-quotes/equity?symbol=MEDANTA

Disclaimer:  At HDFC SKY, we take utmost care and due diligence in curating and presenting news and market-related content. However, inadvertent errors or omissions may occasionally occur.

If you have any concerns, questions, or wish to point out any discrepancies in our content, please feel free to write to us at content@hdfcsec.com.

Please note that the information shared is intended solely for informational purposes and does not make any investment recommendations